3,4-Methylenedioxyamphetamine

From WikiMD's WELLNESSPEDIA

(Redirected from Methylenedioxyamphetamine)

2D skeletal structure of 3,4-Methylenedioxyamphetamine
File:MDA molecule ball.png
Ball-and-stick model of the MDA molecule

3,4-Methylenedioxyamphetamine (MDA) is a synthetic psychoactive drug of the amphetamine class. It is known for its stimulant and hallucinogenic properties and is chemically related to MDMA (3,4-methylenedioxy-N-methylamphetamine), commonly known as ecstasy.

Chemical Structure and Properties[edit]

MDA is a member of the phenethylamine and amphetamine chemical classes. Its chemical formula is C10H13NO2, and it has a molecular weight of 179.22 g/mol. The structure of MDA includes a methylenedioxy group attached to the phenyl ring, which is responsible for its psychoactive effects.

Pharmacology[edit]

MDA acts primarily as a serotonin-norepinephrine-dopamine releasing agent (SNDRA). It increases the levels of these neurotransmitters in the brain, leading to its stimulant and empathogenic effects. MDA is known to produce feelings of euphoria, increased energy, and altered sensory perception.

Effects[edit]

The effects of MDA can vary depending on the dose and individual sensitivity. Common effects include:

  • Euphoria
  • Increased energy and alertness
  • Enhanced sensory perception
  • Emotional openness and empathy
  • Mild hallucinations

History and Use[edit]

MDA was first synthesized in the early 20th century and was initially investigated for potential therapeutic uses. However, due to its psychoactive properties, it became popular as a recreational drug in the 1960s and 1970s. MDA is often used in social settings for its mood-enhancing effects.

Legal Status[edit]

MDA is classified as a Schedule I controlled substance in many countries, including the United States, due to its potential for abuse and lack of accepted medical use.

Related Compounds[edit]

MDA is closely related to several other compounds, including:

  • MDMA
  • MDEA (3,4-methylenedioxy-N-ethylamphetamine)
  • MBDB (3,4-methylenedioxy-N-methylbenzodioxolylbutanamine)

Related Pages[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=3,4-Methylenedioxyamphetamine&oldid=6579948"